Dimedrol-Darnitsa
Release form:
Release form:
Treatment of allergic reactions: urticaria, allergic rhinitis, angioneurotic oedema, serum sickness, contact dermatitis, erythema multiforme, eczema, pruritis, haemorrhagic vasculitis (capillary toxicosis), vasomotor rhinitis, respiratory allergy, acute iridocyclitis. Allergic eye diseases (conjunctivitis). For the prevention and treatment of allergic complications, with the aim of reducing the adverse effects of medicines (antibiotics, enzymes), in blood or blood substitute transfusions. Chorea, motion sickness, Ménière's disease. As a sedative-hypnotic drug in neurosis, neurasthenia, insomnia.